MULTIPLE MYELOMA

general

A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)

100

Centers

1,292

Active Trials

$384M

Cancer Funding

Specific Cancer Types(4)

Top Centers for MULTIPLE MYELOMA(100)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
88.8
2
High-Volume Research Center
86.6
3
NCI Comprehensive
High-Volume Research Center
81.4
4
NCI Comprehensive
High-Volume Research Center
79.6
5
NCI Comprehensive
High-Volume Research Center
79.3
6
NCI Comprehensive
High-Volume Research Center
79.2
7
NCI Comprehensive
High-Volume Research Center
76.8
8
NCI Comprehensive
High-Volume Research Center
76.5
9
NCI Comprehensive
High-Volume Research Center
75.7
10
High-Volume Research Center
75.0
11
High-Volume Research Center
74.6
12
NCI Comprehensive
High-Volume Research Center
74.4
13
High-Volume Research Center
72.8
14
High-Volume Research Center
72.7
15
NCI Comprehensive
High-Volume Research Center
71.4
16
NCI Clinical
High-Volume Research Center
71.2
17
NCI Comprehensive
High-Volume Research Center
70.6
18
NCI Comprehensive
Active Research Program
68.5
19
Active Research Program
67.5
20
NCI Comprehensive
Active Research Program
67.5
2166.8
22
NCI Clinical
Active Research Program
65.8
23
NCI Comprehensive
Active Research Program
65.6
24
NCI Comprehensive
Active Research Program
64.3
25
Active Research Program
60.9
26
NCI Comprehensive
Active Research Program
60.4
27
NCI Comprehensive
Active Research Program
59.6
28
NCI Comprehensive
Active Research Program
59.2
29
NCI Comprehensive
Active Research Program
58.8
30
Active Research Program
58.4
31
NCI Comprehensive
Active Research Program
57.6
32
Active Research Program
57.5
33
NCI Comprehensive
Active Research Program
57.3
34
NCI Comprehensive
Active Research Program
57.2
35
NCI Comprehensive
Active Research Program
57.0
36
Active Research Program
56.2
37
NCI Comprehensive
Active Research Program
56.0
38
NCI Comprehensive
Active Research Program
55.7
39
NCI Comprehensive
Active Research Program
55.6
40
NCI Comprehensive
Active Research Program
54.3
41
NCI Comprehensive
Active Research Program
54.2
42
Active Research Program
53.9
43
NCI Comprehensive
Active Research Program
53.6
44
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
53.2
45
Active Research Program
53.0
46
NCI Basic_laboratory
Active Research Program
52.8
47
NCI Comprehensive
Active Research Program
52.5
48
NCI Comprehensive
Active Research Program
51.8
49
Active Research Program
51.4
50
NCI Comprehensive
Active Research Program
51.1
51
NCI Comprehensive
Active Research Program
50.9
52
NCI Comprehensive
Active Research Program
50.4
53
BC CancerVancouver, BC
Active Research Program
50.3
54
NCI Comprehensive
Active Research Program
50.3
55
NCI Comprehensive
Active Research Program
49.7
56
NCI Comprehensive
Active Research Program
49.3
57
NCI Comprehensive
Active Research Program
48.6
58
Active Research Program
48.5
59
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
47.8
60
NCI Comprehensive
Active Research Program
47.8
61
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.0
62
NCI Comprehensive
Active Research Program
46.9
63
NCI Comprehensive
Active Research Program
46.5
64
NCI Comprehensive
Active Research Program
45.8
65
Active Research Program
45.4
66
NCI Comprehensive
Active Research Program
45.4
67
NCI Comprehensive
Active Research Program
44.0
68
NCI Clinical
Active Research Program
43.0
69
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.9
70
NCI Comprehensive
Active Research Program
42.9
71
NCI Clinical
Active Research Program
42.3
72
Active Research Program
41.1
7340.9
74
Active Research Program
38.2
75
NCI Comprehensive
Active Research Program
36.2
76
NCI Clinical
Active Research Program
35.0
77
Contributing Research Center
34.8
78
Contributing Research Center
34.8
79
Contributing Research Center
34.8
80
WVU Cancer InstituteMorgantown, WV
Contributing Research Center
33.9
81
NCI Comprehensive
Contributing Research Center
33.2
82
Contributing Research Center
30.7
83
NCI Basic_laboratory
Contributing Research Center
30.5
84
Contributing Research Center
30.5
85
NCI Comprehensive
Contributing Research Center
30.5
86
NCI Clinical
Contributing Research Center
30.5
87
Contributing Research Center
30.5
88
NCI Comprehensive
Contributing Research Center
26.9
89
Contributing Research Center
26.9
90
Contributing Research Center
26.9
91
NCI Basic_laboratory
Contributing Research Center
25.9
92
NCI Clinical
Contributing Research Center
23.6
93
NCI Comprehensive
Contributing Research Center
23.6
94
Contributing Research Center
23.6
95
Contributing Research Center
23.6
9619.0
9719.0
98
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
19.0
9919.0
10019.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →